Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
12 mei 2016 - 07:05
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug reports First Quarter 2016 Business Update
Bericht
Probiodrug reports First Quarter 2016 Business Update
HALLE/SAALE, Germany, 12 May 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announces its first quarter business update for the period ending 31 March 2016, in the form of an interim management report.
The interim management report for the first quarter 2016 is available for download on the company website (http://www.probiodrug.de/investors/reports-and-presentations/).
Datum laatste update: 18 december 2025